Cephalosporin

drug
On this page

Summary

Cephalosporin (CHEMBL5482975) is a phase-3 clinical-stage unknown; indicated across 2 conditions including pneumonia.

At a glance

  • Status: Max clinical phase 3 (not approved)
  • Modality: Unknown
  • Indications: 2 conditions
  • Clinical trials: 10

Identifiers

Drug identity and classification

FieldValue
ChEMBL IDCHEMBL5482975
NameCephalosporin
TypeUnknown
Max phase3

Also known as: Cephalosporin, cephalosporin, CEPHALOSPORIN

Targets

Targets

No target linkage available.

Bioactivity

No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).

Target pathways

No target-pathway data for this drug (no mapped target genes).

Indications & clinical

Indications

2 indications (0 at ChEMBL trial phase 4). Phase below is the highest clinical-trial phase recorded for this drug against each disease — not the molecule’s overall approval status (that is in the Summary).

IndicationTrial phaseMONDOEFO
pneumonia3MONDO:0005249EFO:0003106

1 further indication record had no mapped disease name (EFO/MeSH-only) or were duplicates, and are omitted.

Clinical trials

Total trials: 10.

Phase distribution

PhaseTrials
Not specified5
PHASE44
PHASE31

Top trials by phase / activity

NCTPhaseStatusTitle
NCT02913118PHASE4UNKNOWNAdjunctive Therapy of Andrographolid Sulfonatein Community Acquired Pneumonia
NCT04062175PHASE4COMPLETEDEfficacy of Adding Azithromycin to Cephalosporin Before Cesarean Delivery
NCT04401553PHASE4WITHDRAWNProphylactic Antibiotics for Surgical Site Infections and Beta-Lactam Allergy
NCT05094154PHASE4COMPLETEDEffect of Antibiotic Choice On ReNal Outcomes (ACORN)
NCT05267977PHASE3WITHDRAWNAntibiotic Use & Open Fracture of the Lower Extremity
NCT07442357Not specifiedNOT_YET_RECRUITINGThe Per-procedural Antibiotic Prophylaxis in Patients Undergoing Transcatheter Aortic Valve Implantation Trial
NCT01750385Not specifiedUNKNOWNBacteremia and Procalcitonin Levels in Peroral Endoscopic Myotomy for Achalasia
NCT02314013Not specifiedUNKNOWNRandomized Clinical Trial for the Uncomplicated Diverticulitis in Right Colon
NCT02490293Not specifiedCOMPLETEDIs it Fair to Use Antibiotics After Laparoscopic Cholecystectomy for the Patients With Acutely Inflamed Gallbladder?
NCT03917134Not specifiedUNKNOWNPrevention of Vaginal Cellulitis or Vaginal Cuff Abscess After Laparoscopic Hysterectomy

Clinical evidence (CIViC)

No CIViC predictive evidence (expected for non-precision-medicine drugs).

Pharmacology

Pharmacogenomics

No PharmGKB pharmacogenomic data curated for this drug.

No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).